Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Preclinical pharmacology profile of BMS NEP/ACE inhibitors described

Jan. 8, 1997

No Comments

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Jan. 8, 1997

No Comments

Beta-blockers underused

Jan. 7, 1997

No Comments

P&U discontinues development of agent for DVT; Cytel regains development rights

Jan. 7, 1997

No Comments

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

No Comments

bFGF enters clinical trials for PVD

Jan. 3, 1997

No Comments

T Cell Sciences describes anti-CETP vaccines

Jan. 2, 1997

No Comments

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

No Comments

FDA clears angiotensin II blocker from Ciba

Dec. 31, 1996

No Comments

Combination antihypertensive product cleared by FDA

Dec. 31, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cardiovascular, BioWorld Science
RSS

Preclinical pharmacology profile of BMS NEP/ACE inhibitors described

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Beta-blockers underused

P&U discontinues development of agent for DVT; Cytel regains development rights

Andrx freed to market Dilacor XR bioequivalent

bFGF enters clinical trials for PVD

T Cell Sciences describes anti-CETP vaccines

Nissan Chemical discloses novel cardiovascular agents

FDA clears angiotensin II blocker from Ciba

Combination antihypertensive product cleared by FDA

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Cardiovascular, BioWorld Science RSS

Cardiovascular, BioWorld Science
RSS